CPX-1 (Irinotecan HCl: Floxuridine) Liposome Injection
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CPX-1 (Irinotecan HCl: Floxuridine) Liposome Injection, covering 2021-07-02 to 2021-07-02. Get the full timeline:
Most recent: Clinical Trial Update: Multicenter Study Of CPX-1 (Irinotecan HCl: Floxuridine) Liposome Injection In Patients With Advanced Colorectal Cancer [Phase 2]